NBY missed EPS expectations by 10.72%
Aug 13, 2024, 9:37 PM
0.00%
What does NBY do
NovaBay Pharmaceuticals, Inc., based in Emeryville, California, specializes in developing and selling clinically proven eyecare and skincare products, including its flagship Avenova Antimicrobial Lid & Lash Solution. The company, which launched its IPO in 2007, markets about 30 dermatologist-developed products through its subsidiary DERMAdoctor, LLC, addressing various skin concerns.
Novabay Pharmaceuticals (NBY) reported a negative EPS surprise in its most recent quarterly earnings. For the most recent quarter, Novabay Pharmaceuticals's actual EPS was -$1.37, missing the estimate of -$1.24 per share, resulting in a -10.72% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.